Nav: Home

Drug makes stem cells become 'embryonic' again

March 17, 2016

ANN ARBOR, Mich. -- If you want to harness the full power of stem cells, all you might need is an eraser.

Not an ordinary eraser, of course. More of a drug, really. But if you use it right, it can erase the tiny labels that tell cells where to start reading important chapters in DNA, their inner instruction manual.

And if they can't read that manual, the cells regain their full stem cell power - the power to become any kind of cell in the body.

In a surprising new finding, University of Michigan Medical School scientists have shown that a drug developed at U-M can achieve this -- at least in mice.

It's the first time that scientists have shown they can get stem cells to revert to their original state by erasing specific labels called epigenetic markers. The drug specifically targets markers on histones, the protein "spools" that DNA coils around to create structures called chromatin.

"Magic" eraser

Writing in the journal Cell Stem Cell, the team reports that more than half of mouse epiblast stem cells treated with the drug reversed course within three days, and regained an embryonic "be anything" state, also called pluripotency.

In addition to generating pluripotent stem cells, the team showed that mice bred using the cells grew up healthy.

"We've demonstrated that we don't have to manipulate the pluripotent genes to get to the ground state, but rather that we can block all other options of where the cell 'wants' to go. Then the only option is going back to the ground, or naïve, pluripotent state," says Yali Dou, Ph.D., senior author of the new paper and an associate professor of pathology and biological chemistry at U-M.

The researchers used a relatively new compound called MM-401, which U-M scientists originally designed for use in treating leukemia. Now, they're working to see if the MM-401 eraser technique works with human stem cells that bear some resemblance to mouse epiblast stem cells. They will share the drug with any other researchers who want to try the technique.

However, it's far too early to see the approach as a way to avoid the use of human embryos for research or potential treatments. Currently, embryos left over from infertility treatments are the only source of human embryonic stem cells.

Other techniques can reprogram "adult" cells in the human body taken from skin, for example -- but the cells still carry baggage from their previous state.

Still, the new achievement shows the power of altering the epigenetic labels that dot the chromatin packaging, without altering the DNA itself. Past attempts by other teams to restore pluripotency to mouse cells from the epiblast stem cell state have yielded far lower amounts, or non-viable cells. And, they've required cocktails of multiple drugs, given over the long term, to achieve it.

The U-M team shows that using MM-401 for just a few days, and then stopping its use, is enough.

The first author of the new paper is Hui Zhang, Ph.D., a postdoctoral fellow in Dou's laboratory.

Epigenetic maneuvers

Epigenetic labels signal to the cell's DNA-reading machinery where they should start uncoiling a chromosome in order to read it. The U-M-developed drug targets the labels that come from the activity of a gene called MLL1.

MLL1 plays a key role in the uncontrolled explosion of white blood cells that's the hallmark of leukemia, which is why U-M researchers originally developed MM-401 to interfere with it. But it also plays a much more mundane role in regular cell development, and the formation of blood cells and the cells that form the spinal cord in later-stage embryos.

It does this by placing tiny tags -- called methyl groups -- on histones. Without those labels, the cell's DNA-reading machinery doesn't know where to start reading. It's as if the invitation to open the instruction manual had vanished.

Stem cells don't harness the power of MLL1 until they're older. So using MM-401 to block MLL1's normal activity in cells that had started down the path to adulthood meant that histone marks were missing before the cell needed them. The cells couldn't continue on their journey to becoming different types of cells. But they could still function as healthy pluripotent stem cells.

"People have been focused on other epigenetic changes that are more dramatic, but ignored methylation by the MLL family," says Dou. "Deleting MLL1 entirely causes failure later in differentiation. But inhibiting it with a drug temporarily leaves no trace behind."

The U-M team that designed MM-401 is led by co-author Shaomeng Wang, Ph.D., the Warner-Lambert/Parke-Davis Professor at the Medical School who holds appointments in internal medicine and pharmacology, as well as an appointment in the U-M College of Pharmacy.

The team also included Sundeep Kalantry, Ph.D., an assistant professor of human genetics at U-M who showed that female stem cells treated with MM-401 had un-silenced one of their X chromosomes. This step is crucial for showing that cells have returned to true pluripotency.

Alexey Nesvizhskii, Ph.D., and his colleagues in Pathology and Computational Medicine and Bioinformatics contributed important analysis to show how changes in MLL1 expression affects other gene expression in cells.
-end-
The work was funded by the National Institutes of Health (GM082856, OD008646, GM094231, CA117307) and by the Leukemia and Lymphoma Society. U-M holds a patent on MM-401 and has licensed it to Ascentage Pharma, a China-based company co-founded by Wang in which the university holds equity.

Reference:Cell Stem Cell , http://dx.doi.org/10.1016/j.stem.2016.02.004.

University of Michigan Health System

Related Stem Cells Articles:

A protein that stem cells require could be a target in killing breast cancer cells
Researchers have identified a protein that must be present in order for mammary stem cells to perform their normal functions.
Approaching a decades-old goal: Making blood stem cells from patients' own cells
Researchers at Boston Children's Hospital have, for the first time, generated blood-forming stem cells in the lab using pluripotent stem cells, which can make virtually every cell type in the body.
New research finds novel method for generating airway cells from stem cells
Researchers have developed a new approach for growing and studying cells they hope one day will lead to curing lung diseases such as cystic fibrosis through 'personalized medicine.'
Mature heart muscle cells created in the laboratory from stem cells
Generating mature and viable heart muscle cells from human or other animal stem cells has proven difficult for biologists.
Mutations in bone cells can drive leukemia in neighboring stem cells
DNA mutations in bone cells that support blood development can drive leukemia formation in nearby blood stem cells.
Scientists take aging cardiac stem cells out of semiretirement to improve stem cell therapy
With age, the chromosomes of our cardiac stem cells compress as they move into a state of safe, semiretirement.
Purest yet liver-like cells generated from induced pluripotent stem cells
A team of researchers from the Medical University of South Carolina and elsewhere has found a better way to purify liver cells made from induced pluripotent stem cells.
Stem cell scientists discover genetic switch to increase supply of stem cells from cord blood
International stem cell scientists, co-led in Canada by Dr. John Dick and in the Netherlands by Dr.
Stem cells from diabetic patients coaxed to become insulin-secreting cells
Signaling a potential new approach to treating diabetes, researchers at Washington University School of Medicine in St.

Related Stem Cells Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Don't Fear Math
Why do many of us hate, even fear math? Why are we convinced we're bad at it? This hour, TED speakers explore the myths we tell ourselves and how changing our approach can unlock the beauty of math. Guests include budgeting specialist Phylecia Jones, mathematician and educator Dan Finkel, math teacher Eddie Woo, educator Masha Gershman, and radio personality and eternal math nerd Adam Spencer.
Now Playing: Science for the People

#518 With Genetic Knowledge Comes the Need for Counselling
This week we delve into genetic testing - for yourself and your future children. We speak with Jane Tiller, lawyer and genetic counsellor, about genetic tests that are available to the public, and what to do with the results of these tests. And we talk with Noam Shomron, associate professor at the Sackler School of Medicine at Tel Aviv University, about technological advancements his lab has made in the genetic testing of fetuses.